Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EPC stock price vs PFE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PFE's multiple
Needs Annual EPS, PFE P/E.
Implied fair value · at EPC's multiple
Needs Annual EPS, EPC P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EDGEWELL PERSONAL CARE Co · implied price per share
Reporting currency could not be verified.
PFIZER INC · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
EPC · not enough data.
PFE · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PROCTER & GAMBLE Co
EPC vs PG
COLGATE PALMOLIVE CO
EPC vs CL
CHURCH & DWIGHT CO INC /DE/
EPC vs CHD
COTY INC.
EPC vs COTY
JOHNSON & JOHNSON
EPC vs JNJ
Merck & Co., Inc.
EPC vs MRK
AbbVie Inc.
EPC vs ABBV
BRISTOL MYERS SQUIBB CO
EPC vs BMY
ELI LILLY & Co
EPC vs LLY
AMGEN INC
EPC vs AMGN
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe EPC can materially improve margins and reduce leverage from current levels, then consider holding or adding only selectively because the current price still looks rich versus PFE-implied and DCF-based valuation using the provided data.
EPC’s current price of $28.12 is far above PFE-implied price of $10.21, implying 63.7% downside on this framework. The market is also valuing EPC above both its historical band and DCF range, suggesting the relative multiple gap is not supported by the provided intrinsic ranges.
Supporting Metrics
